Current position: Home >> Scientific Research >> Patents

阻断COVID-19棘突状蛋白与人血管紧张素转化酶2结合的小分子抑制剂及其用途

Release Time:2025-12-22  Hits:

Institution: 化工学院制药工程

Type of Patent: Invention

Scope of Patent: 生物与医药

Application Date: 2020-11-20

Application Number: 202011316689.0

Authorization Date: 2022-07-26

Authorization Number: CN 112457281 B

Service Invention or Not: No

Prev One:一种COVID-19棘突状蛋白的小分子抑制剂的筛选方法、其筛选的活性分子及用途

Next One:一种果糖嗪的制备方法及用途